Readouts for two late-stage, potentially registrational trials of nemvaleukin alfa expected in late Q1/early Q2 2025 for platinum-resistant ovarian cancer and Q2 2025 for mucosal melanoma Preliminary ...

The trading of TCE (T Cell Engager) bispecific antibodies remains hot, and multinational pharmaceutical companies (MNCs) are still placing orders frantically.Recently ...

Vir Biotechnology's recent share price rally is driven by their promising cancer program. Having shot to over a $1.5B market ...

CAMBRIDGE, Mass., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA), a leader in cell therapies for the ...

WHO has further stated that HMPV is a common respiratory virus found to circulate in many countries in winter through to ...

Immunotherapy represents a groundbreaking approach to combating various diseases by harnessing and enhancing the body’s ...

Skin, as the largest organ of the human body, is influenced by exposure to environmental factors such as UV radiation, which ...

A live webcast of the presentation will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with ...

NSW Health advises HMPV is prone to resolving within one to 10 days of infection. Unlike Covid, the average person is likely ...

In a large-animal model study, researchers have found that heart attack recovery is aided by the injection of heart muscle ...

TOPLINE: Sjögren disease (SjD) presents three distinct phenotypes ― B-cell active with low symptom burden, high systemic ...

Familiar with the powerful influence of the gut–brain axis, Maraganore and his team set out to investigate how the ...